Title: Cystic Fibrosis as a Cause of Malabsorption and Increased Requirement of Levothyroxine
Abstract: ThyroidVol. 30, No. 7 Letter to the EditorCystic Fibrosis as a Cause of Malabsorption and Increased Requirement of LevothyroxineGiuseppe Giuffrida, Giuseppe Magazzù, Alfredo Campennì, Maria Cristina Lucanto, Francesco Trimarchi, Salvatore Cannavò, and Rosaria M. RuggeriGiuseppe GiuffridaEndocrine Unit; Messina, Italy.Department of Clinical and Experimental Medicine; Messina, Italy.Search for more papers by this author, Giuseppe MagazzùDepartment of Human Pathology of Adulthood and Childhood "Gaetano Barresi"; Messina, Italy.Search for more papers by this author, Alfredo CampennìDepartment of Biomedical and Dental Sciences and Morpho-Functional Imaging; Messina, Italy.Search for more papers by this author, Maria Cristina LucantoDepartment of Human Pathology of Adulthood and Childhood "Gaetano Barresi"; Messina, Italy.Search for more papers by this author, Francesco TrimarchiAccademia Peloritana dei Pericolanti; University of Messina, Messina, Italy.Search for more papers by this author, Salvatore CannavòEndocrine Unit; Messina, Italy.Department of Human Pathology of Adulthood and Childhood "Gaetano Barresi"; Messina, Italy.Search for more papers by this author, and Rosaria M. RuggeriAddress correspondence to: Rosaria Maddalena Ruggeri, MD, PhD, Endocrine Unit, Department of Clinical and Experimental Medicine, University of Messina, Building H, "Gaetano Martino" University Hospital, Messina 98125, Italy E-mail Address: [email protected] Unit; Messina, Italy.Department of Clinical and Experimental Medicine; Messina, Italy.Search for more papers by this authorPublished Online:10 Jul 2020https://doi.org/10.1089/thy.2019.0574AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"Cystic Fibrosis as a Cause of Malabsorption and Increased Requirement of Levothyroxine." Thyroid, 30(7), pp. 1095–1096FiguresReferencesRelatedDetailsCited byManagement of Endocrine and Metabolic Toxicities of Immune-Checkpoint Inhibitors: From Clinical Studies to a Real-Life Scenario30 December 2022 | Cancers, Vol. 15, No. 1Levothyroxine: Conventional and Novel Drug Delivery Formulations22 November 2022 | Endocrine Reviews, Vol. 390Commentary: L-T4 Therapy in Enteric Malabsorptive Disorders25 June 2021 | Frontiers in Endocrinology, Vol. 12Thyroid hormones, iodine, and iodides, and antithyroid drugs Volume 30Issue 7Jul 2020 InformationCopyright 2020, Mary Ann Liebert, Inc., publishersTo cite this article:Giuseppe Giuffrida, Giuseppe Magazzù, Alfredo Campennì, Maria Cristina Lucanto, Francesco Trimarchi, Salvatore Cannavò, and Rosaria M. Ruggeri.Cystic Fibrosis as a Cause of Malabsorption and Increased Requirement of Levothyroxine.Thyroid.Jul 2020.1095-1096.http://doi.org/10.1089/thy.2019.0574Published in Volume: 30 Issue 7: July 10, 2020Online Ahead of Print:May 14, 2020Online Ahead of Editing: April 20, 2020PDF download
Publication Year: 2020
Publication Date: 2020-04-21
Language: en
Type: letter
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 4
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot